It has been demonstrated that TRIM37 facilitates the invasion and metastatic ability of cells in gastric cancer and hepatocellular carcinoma via activation of the epithelial-mesenchymal transition (EMT) and Wnt/β-catenin signaling pathway, respectively [18,29]. Here, TRIM37 is linked to hepatocellular carcinoma.